1. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ (2003) Circulation 107(23): 2920-5
    › Primary publication · 12771006 (PubMed)
  2. Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart Study. Freitag MH, Larson MG, Levy D, Benjamin EJ, Wang TJ, Leip EP, Wilson PW, Vasan RS, Framingham Heart Study (2003) Hypertension 41(4): 978-83
    › Primary publication · 12623868 (PubMed)
  3. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS (2003) Circulation 108(8): 977-82
    › Primary publication · 12912813 (PubMed)
  4. Heritability and genetic linkage of plasma natriuretic peptide levels. Wang TJ, Larson MG, Levy D, Benjamin EJ, Corey D, Leip EP, Vasan RS (2003) Circulation 108(1): 13-6
    › Primary publication · 12821537 (PubMed)
  5. Carotid intima-media thickness is associated with premature parental coronary heart disease: the Framingham Heart Study. Wang TJ, Nam BH, D'Agostino RB, Wolf PA, Lloyd-Jones DM, MacRae CA, Wilson PW, Polak JF, O'Donnell CJ (2003) Circulation 108(5): 572-6
    › Primary publication · 12874190 (PubMed)
  6. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D'Agostino RB, Larson MG, Kannel WB, Benjamin EJ (2003) JAMA 290(8): 1049-56
    › Primary publication · 12941677 (PubMed)
  7. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. Vasan RS, Benjamin EJ, Larson MG, Leip EP, Wang TJ, Wilson PW, Levy D (2002) JAMA 288(10): 1252-9
    › Primary publication · 12215132 (PubMed)
  8. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, Sutherland P, Omland T, Vasan RS (2002) Am J Cardiol 90(3): 254-8
    › Primary publication · 12127613 (PubMed)
  9. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Wang TJ, Larson MG, Levy D, Benjamin EJ, Kupka MJ, Manning WJ, Clouse ME, D'Agostino RB, Wilson PW, O'Donnell CJ (2002) Circulation 106(10): 1189-91
    › Primary publication · 12208790 (PubMed)
  10. A utilization management intervention to reduce unnecessary testing in the coronary care unit. Wang TJ, Mort EA, Nordberg P, Chang Y, Cadigan ME, Mylott L, Ananian LV, Thompson BT, Fessler M, Warren W, Wheeler A, Jordan M, Fifer MA (2002) Arch Intern Med 162(16): 1885-90
    › Primary publication · 12196088 (PubMed)